Line 1,182: |
Line 1,182: |
| | || | | | || |
| |- | | |- |
| + | |Cold agglutinin disease |
| + | |Disease |
| | | | | |
| | | | | |
Line 1,187: |
Line 1,189: |
| | | | | |
| | | | | |
− | | | + | |SG |
− | |
| |
− | |
| |
| | | | | |
| | | | | |
| | | | | |
| |- | | |- |
− | | || || || || || || || || | + | |IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| |
| | || | | | || |
| |- | | |- |
− | | || || || || || || || || | + | |Non-IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| |
| | || | | | || |
| |- | | |- |
− | | || || || || || || || | + | |Monoclonal gammopathy of renal significance||Disease|| || || || || ||SG |
| | | | | |
| | || | | | || |
| |- | | |- |
− | | || || || || || || || | + | |Immunoglobulin-related (AL) amyloidosis||Disease||Heather E. Williams, PhD, MS, PgD, ErCLG|| || || || ||SG |
| | | | | |
| | || | | | || |
| |- | | |- |
− | | || || || || || || || | + | |Monoclonal immunoglobulin deposition disease||Disease||Chen Yang, MD, PhD, University of Michigan|| || || || ||SG |
| | | | | |
| | || | | | || |
| |- | | |- |
− | | || || || || || || || | + | |Mu heavy chain disease||Disease|| || || || || ||SG |
| | | | | |
| | || | | | || |
| |- | | |- |
− | | || || || || || || || | + | |Gamma heavy chain disease||Disease||Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA|| || || || ||SG |
| | | | | |
| | || | | | || |
| |- | | |- |
− | | || || || || || || || | + | |Alpha heavy chain disease||Disease|| || || || || ||SG |
| | | | | |
| | || | | | || |
| |- | | |- |
− | | || || || || || || || | + | |Plasmacytoma||Disease|| || || || || ||SG |
| | | | | |
| | || | | | || |
| |- | | |- |
− | | || || || || || || || | + | |Plasma cell myeloma / multiple myeloma||Disease||*Huan Mo, MD, MS *Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas|| || || || ||SG |
| | | | | |
| | || | | | || |
| |- | | |- |
− | | || || || || || || || | + | |Plasma cell neoplasms with associated paraneoplastic syndrome||Disease||Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD|| || || || ||SG |
| | | | | |
| | || | | | || |
| |- | | |- |
− | | || || || || || || || | + | |CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)|| |
| + | ----<br />|| |
| + | ----<br />|| || || || || |
| | | | | |
| | || | | | || |
Line 1,379: |
Line 1,381: |
| | || | | | || |
| |- | | |- |
− | |CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)|| || | + | | || || || || || || || || |
− | ----<br />||
| |
− | ----<br />|| || || || ||
| |
| | || | | | || |
| |- | | |- |
Line 1,412: |
Line 1,412: |
| | | | | |
| |- | | |- |
− | |Cold agglutinin disease||Disease|| || || || || ||SP|| | + | | || || || || || || || || |
| | || | | | || |
| |- | | |- |
− | |IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SP|| | + | | || || || || || || || || |
| | || | | | || |
| |- | | |- |
− | |Non-IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SP|| | + | | || || || || || || || || |
| | || | | | || |
| |- | | |- |
− | |Monoclonal gammopathy of renal significance||Disease|| || || || || ||SP|| | + | | || || || || || || || || |
| | || | | | || |
| |- | | |- |
− | |Immunoglobulin-related (AL) amyloidosis||Disease||Heather E. Williams, PhD, MS, PgD, ErCLG|| || || || ||SP|| | + | | || || || || || || || || |
| | || | | | || |
| |- | | |- |
− | |Monoclonal immunoglobulin deposition disease||Disease||Chen Yang, MD, PhD, University of Michigan|| || || || ||SP|| | + | | || || || || || || || || |
| | || | | | || |
| |- | | |- |
− | |Mu heavy chain disease||Disease|| || || || || ||SP|| | + | | || || || || || || || || |
| | || | | | || |
| |- | | |- |
− | |Gamma heavy chain disease||Disease||Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA|| || || || ||SP|| | + | | || || || || || || || || |
| | || | | | || |
| |- | | |- |
− | |Alpha heavy chain disease||Disease|| || || || || ||SP|| | + | | || || || || || || || || |
| | || | | | || |
| |- | | |- |
− | |Plasmacytoma||Disease|| || || || || ||SP|| | + | | || || || || || || || || |
| | || | | | || |
| |- | | |- |
− | |Plasma cell myeloma / multiple myeloma||Disease||*Huan Mo, MD, MS *Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas|| || || || ||SP|| | + | | || || || || || || || || |
| | || | | | || |
| |- | | |- |
− | |Plasma cell neoplasms with associated paraneoplastic syndrome||Disease||Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD|| || || || ||SP|| | + | | || || || || || || || || |
| | || | | | || |
| |- | | |- |